Autologous oxidized tumor cell lysate vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous oxidized tumor cell lysate vaccine, covering 2021-11-15 to 2021-11-15. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]